Generics
Viatris' generic iron sucrose injection gains US FDA approval
12 August 2025 - Viatris Inc (Nasdaq:VTRS), a US-based global healthcare company, announced on Monday that the US Food and Drug Administration (FDA) has approved Iron Sucrose Injection, USP, an intrav...
Newbury Pharmaceuticals gains Finnish approval for generic melatonin
11 August 2025 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Monday that it has secured marketing authorisation in Finland for Melatonin Newbury 2 mg prolonged-...
CivicaScript to distribute biosimilar for chronic inflammatory conditions
6 August 2025 - CivicaScript LLC, a nonprofit company focused on bringing low-cost generic medicines to US patients, announced on Tuesday that it will distribute the biosimilar ustekinumab-aauz, used ...
Mallinckrodt and Endo complete merger
4 August 2025 - Mallinckrodt plc, an American-Irish pharmaceutical company, and Endo Inc, a Pennsylvania-based pharmaceutical company, announced on Friday that they have completed their merger to crea...
Zenara Pharma's Sertraline Hydrochloride Capsules generic receives US FDA approval
1 August 2025 - India-based Zenara Pharma Private Limited, a Biophore company, announced on Thursday that it has received final approval from the US Food and Drug Administration (FDA) for its Abbrevia...
EQT agrees to acquire majority stake in Adalvo
18 July 2025 - Swedish global investment organisation EQT AB (STO: EQT) announced on Friday that it has agreed with Icelandic private equity company Aztiq to acquire a majority stake in Adalvo, a glob...